StockData
Gelteq Ltd logo

Gelteq Ltd (GELS) stock

GELSNasdaqPharmaceutical PreparationsFiscal year ends June 30
Financials through fiscal 2025, year ended Jun 30, 2025Last filing: 20-F on Nov 17, 2025Score 0/30
$0.38−0.00 (-0.13%)

Close on Nov 13, 2026Market cap $4.07MP/E –Yield –

Gelteq statistics

55 measures from SEC filings and the closing price. Hover a name for the formula; the last column is the median of companies in the same industry group.

Important dates

Next earnings
–
Last ex-dividend date
No dividends
Fundamentals through
Dec 31, 2025
Share price as of
–

Valuation ratiosIndustry

Market Cap
A$5.92M
A$15.59M
Enterprise Value
A$11.03M
A$1.26M
PS Ratio
35.77
–

Enterprise valuationIndustry

EV / Sales
66.59
–

Share statisticsIndustry

Shares Change (YoY)
14.2%
28.6%
Float
9M
317M
Shares Held by Insiders
14.0%
1.94%

Short sellingIndustry

Short Interest
228,185
–
Short Interest Change
-27.5%
-27.5%
Days to Cover
2.08
2.08

Stock price statisticsIndustry

Price Change (1 Week)
-13.6%
-7.80%
Price Change (1 Month)
-11.7%
-11.7%
Price Change (3 Months)
-32.6%
-51.2%
Price Change (6 Months)
-12.7%
-49.7%
Price Change (YTD)
-52.5%
-36.4%
Price Change (1 Year)
-64.1%
-48.3%
Average Volume (10 Days)
27,782
–
Average Volume (20 Days)
75,556
–
Average Volume (90 Days)
2M
–
Relative Volume
0.01
0.81
Relative Strength Index (14)
31.0
31.9
Volatility (1 Year)
229.1%
128.1%
Beta (5 Years)
2.50
1.38

MarginsIndustry

Gross Margin
30.3%
–
Operating Margin
-3317.6%
–
Pretax Margin
-4011.9%
–
EBITDA Margin
-2579.4%
–
FCF Margin
-3335.3%
–

Returns on capitalIndustry

Return on Capital Employed (ROCE)
-38.6%
–

Financial positionIndustry

Current Ratio
0.09
5.69
Quick Ratio
0.07
5.16
Interest Coverage
-2.82
–

EfficiencyIndustry

Asset Turnover
0.01
–
WACC
15.0%
12.0%

Income statement (TTM)Industry

Revenue
A$165.65K
–
Gross Profit
A$50.25K
–
Operating Income
-A$5.50M
–
Pretax Income
-A$6.65M
-A$22.45M
EBITDA
-A$4.27M
–
EPS (Diluted)
-0.72 AUD
–

Balance sheetIndustry

Total Debt
A$5.11M
–
Net Cash (Debt)
-A$5.10M
A$37.32M
Net Cash Per Share
-0.48 AUD
0.04 AUD
Working Capital
-A$5.34M
A$42.67M

Cash flow (TTM)Industry

Operating Cash Flow
-A$5.52M
-A$13.28M
Capital Expenditures
-A$3.12K
–
Free Cash Flow
-A$5.52M
–
FCF Per Share
-0.52 AUD
–

Dividends and yieldsIndustry

FCF Yield
-93.2%
–
Buyback Yield
-133.6%
–
Shareholder Yield
-133.6%
–

Taxes and interestIndustry

Interest Expense
A$1.95M
–

Scores and fair valueIndustry

Altman Z-Score
-0.61
-1.72

Total return vs. the S&P 500

Price change plus reinvested dividends, to the close on Nov 13, 2026. The S&P 500 is measured by the SPY fund.

PeriodGELSS&P 500DifferenceGELS per yearS&P 500 per year
1 month-20.8%-3.0%−17.7 pts
3 months-34.5%-2.8%−31.8 pts
Year to date-52.5%+11.5%−64.0 pts
1 year-62.3%+13.5%−75.8 pts

Short interest

Shares sold short and not yet covered, reported by brokers to FINRA twice a month. Latest settlement date Oct 30, 2026.

0M GELS shares were sold short on Oct 30, 2026, down 27.5% from the previous report. At recent volumes it would take 2.1 days to buy them back. Over the last 20 sessions, 29.9% of the volume reported to FINRA was short selling.

Settlement dateShares shortChangeAvg. daily volumeDays to cover
Oct 30, 2026228,185-27.5%109,8142.1
Oct 15, 2026314,643-39.6%64,9834.8
Sep 30, 2026520,734+138.2%3,172,9051.0
Sep 15, 2026218,607+1305.4%14,143,7771.0
Aug 31, 202615,555+22.9%19,8321.0
Aug 14, 202612,658-62.6%36,0251.0
Jul 31, 202633,877-69.9%168,2011.0
Jul 15, 2026112,420-32.9%41,3842.7
Jun 30, 2026167,463-60.7%447,2831.0
Jun 15, 2026426,471+453.2%19,813,1871.0
May 29, 202677,097-36.3%54,9781.4
May 15, 2026120,948+224.2%274,9191.0

Ratios use trailing-twelve-month results and the latest balance sheet. How we calculate.

See a number that looks wrong?